BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18319335)

  • 1. Modulation of drug resistance by artificial transcription factors.
    Blancafort P; Tschan MP; Bergquist S; Guthy D; Brachat A; Sheeter DA; Torbett BE; Erdmann D; Barbas CF
    Mol Cancer Ther; 2008 Mar; 7(3):688-97. PubMed ID: 18319335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression.
    Satou M; Aizawa S; Hayakari M; Ookawa K; Tsuchida S
    Cancer Sci; 2003 Mar; 94(3):286-91. PubMed ID: 12824923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
    Mahyar-Roemer M; Roemer K
    Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
    Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
    Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
    Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
    Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
    Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM
    Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
    Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
    Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic reprogramming of tumor cells by zinc finger transcription factors.
    Blancafort P; Chen EI; Gonzalez B; Bergquist S; Zijlstra A; Guthy D; Brachat A; Brakenhoff RH; Quigley JP; Erdmann D; Barbas CF
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11716-21. PubMed ID: 16081541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
    Cuddihy AR; Jalali F; Coackley C; Bristow RG
    Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate.
    Joseph J; Wajapeyee N; Somasundaram K
    Int J Cancer; 2005 May; 115(1):11-8. PubMed ID: 15688418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and characterization of taxol-resistance phenotypes with a transiently expressed artificial transcriptional activator library.
    Lee DK; Kim YH; Kim JS; Seol W
    Nucleic Acids Res; 2004 Aug; 32(14):e116. PubMed ID: 15304545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.